OVER EXPRESSION OF CD44V8-10 IN URINARY EXFOLIATED CELLS AS AN INDEPENDENT PROGNOSTIC PREDICTOR IN PATIENTS WITH UROTHELIAL CANCER
Authors:
- 1 March 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (3) , 1282-1287
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- URINARY CYTOLOGY AND COMPETITIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION ANALYSIS OF A SPECIFIC CD44 VARIANT TO DETECT AND MONITOR BLADDER CANCERJournal of Urology, 1998
- Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder CancerJNCI: Journal of the National Cancer Institute, 1997
- Increased Expression of CD44 Variants in Differentiated Thyroid CancersJapanese Journal of Cancer Research, 1996
- Molecular Detection of Primary Bladder Cancer by Microsatellite AnalysisScience, 1996
- CD44 expression patterns in breast and colon tumors: A pcr‐based study of splice variantsInternational Journal of Cancer, 1995
- Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder‐carcinoma cell linesInternational Journal of Cancer, 1995
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.Journal of Experimental Medicine, 1994
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Novel variants of CD44 arising from alternative splicing: Changes in the CD44 alternative splicing pattern of MCF‐7 breast carcinoma cells treated with hyaluronidaseMolecular Carcinogenesis, 1993
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991